Price range: £237.71 through £549.71
LL-37 is an LL-37 peptide that researchers use to explore innate immune defense and antimicrobial signaling in controlled laboratory settings. It is derived from the human cathelicidin precursor protein (hCAP-18) and plays a significant role in host-protective immune responses. Because the LL-37 peptide interacts with both pathogens and immune receptors, it supports advanced research in microbiology, immunology, and cellular communication.
Scientists value LL-37 for its ability to disrupt microbial membranes while also modulating immune-cell signaling. It enables studies on inflammatory pathways, wound response behavior, and epithelial barrier mechanisms. Additionally, the LL-37 peptide serves as a model for evaluating multifunctional peptides that exhibit antimicrobial activity as well as regulatory influence over cytokine-driven responses.
Common research applications for the LL-37 peptide include:
Studying antimicrobial activity in vitro
Mapping innate-immune signaling interactions
Analysing inflammatory responses and cytokine modulation
Examining epithelial defense and tissue-repair pathways
Because LL-37 performs consistently in controlled environments, it supports reliable mechanistic modeling and data reproducibility. Its dual functional role makes it highly relevant for research programs that examine both pathogen defense and immune-regulation processes simultaneously.
Our LL-37 peptide is manufactured as a high-purity laboratory reagent intended solely for trained scientific professionals. It is not approved for human or veterinary administration, and no therapeutic or diagnostic claims are made. All users must follow institutional safety practices and regulatory guidelines for investigational peptides.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
